AstraZeneca says it is still aiming to supply 180 million doses of its COVID-19 vaccine to the European Union in the second quarter of the year, despite media reports to the contrary.
“AstraZeneca confirms today that its most recent Q2 forecast for the delivery of its COVID-19 vaccine aims to deliver in line with its contract with the European Commission. As per this contract, approximately half of the expected volume is due to come from the EU supply chain, while the remainder would come from its international supply network,” said a spokesperson for AstraZeneca in an emailed statement.
“At this stage AstraZeneca is working to increase productivity in its EU supply chain and to continue to make use of its global capability in order to achieve delivery of 180 million doses to the EU in the second quarter,” the spokesperson added.